HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhong Chen Selected Research

Histamine H2 Receptors

5/2015Histamine promotes locomotion recovery after spinal cord hemisection via inhibiting astrocytic scar formation.
10/2014Histamine upregulates Nav1.8 expression in primary afferent neurons via H2 receptors: involvement in neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhong Chen Research Topics

Disease

172Neoplasms (Cancer)
05/2024 - 08/2002
50Squamous Cell Carcinoma of Head and Neck
01/2023 - 06/2002
49Seizures (Absence Seizure)
01/2024 - 04/2002
49Inflammation (Inflammations)
12/2023 - 10/2004
48Epilepsy (Aura)
04/2024 - 01/2004
37Ischemia
07/2023 - 10/2002
33Infections
05/2024 - 06/2005
30Hepatocellular Carcinoma (Hepatoma)
03/2024 - 01/2017
26Brain Ischemia (Cerebral Ischemia)
11/2022 - 10/2002
25Prostatic Neoplasms (Prostate Cancer)
11/2023 - 05/2007
25Neoplasm Metastasis (Metastasis)
01/2023 - 08/2004
24Carcinogenesis
01/2023 - 08/2004
24Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 09/2002
19Wounds and Injuries (Trauma)
11/2023 - 01/2004
17Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2005
16Myocardial Infarction
04/2024 - 06/2007
16Cicatrix (Scar)
04/2024 - 01/2002
16Temporal Lobe Epilepsy
02/2024 - 01/2007
16Pain (Aches)
01/2023 - 09/2010
15Carcinoma (Carcinomatosis)
08/2023 - 09/2002
13Infarction (Infarctions)
04/2024 - 01/2005
13Fibrosis (Cirrhosis)
12/2023 - 12/2013
13Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 09/2002
12Hypoxia (Hypoxemia)
05/2024 - 10/2002
12Type 2 Diabetes Mellitus (MODY)
12/2022 - 01/2010
12Brain Injuries (Brain Injury)
11/2022 - 08/2005
12Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 05/2009
11Ischemic Stroke
04/2024 - 08/2005
11Liver Neoplasms (Liver Cancer)
06/2023 - 04/2012
11Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2023 - 04/2006
11Heart Failure
01/2022 - 11/2011
10Stroke (Strokes)
04/2024 - 04/2011
10Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 06/2006
10Neuralgia (Stump Neuralgia)
11/2022 - 01/2011
10Necrosis
06/2016 - 03/2006
9Stomach Neoplasms (Stomach Cancer)
01/2022 - 02/2009
9Lung Neoplasms (Lung Cancer)
01/2021 - 08/2009
9Memory Disorders (Memory Loss)
01/2019 - 01/2002
8Ventricular Tachycardia
04/2024 - 02/2012
8Hypersensitivity (Allergy)
01/2023 - 10/2014
7Drug Resistant Epilepsy
01/2024 - 09/2010
7Cognitive Dysfunction
12/2023 - 10/2002
7Alzheimer Disease (Alzheimer's Disease)
12/2023 - 04/2002
7Hemorrhage
01/2023 - 09/2004
7Breast Neoplasms (Breast Cancer)
01/2023 - 08/2002
7Body Weight (Weight, Body)
01/2022 - 06/2003
7Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 07/2014

Drug/Important Bio-Agent (IBA)

78Proteins (Proteins, Gene)FDA Link
02/2024 - 12/2006
40Histamine (Histamine Dihydrochloride)FDA Link
01/2023 - 01/2002
39Biomarkers (Surrogate Marker)IBA
03/2024 - 12/2004
34CytokinesIBA
03/2023 - 06/2002
30Transcription Factors (Transcription Factor)IBA
10/2020 - 06/2002
28Glucose (Dextrose)FDA LinkGeneric
10/2023 - 08/2005
26MicroRNAs (MicroRNA)IBA
06/2023 - 01/2013
24NF-kappa B (NF-kB)IBA
01/2022 - 06/2002
22Oxygen (Dioxygen)IBA
05/2024 - 06/2003
21Messenger RNA (mRNA)IBA
01/2023 - 01/2002
16Therapeutic UsesIBA
04/2024 - 01/2006
15Long Noncoding RNAIBA
01/2022 - 10/2016
15Phosphotransferases (Kinase)IBA
01/2020 - 06/2002
14RNA (Ribonucleic Acid)IBA
01/2024 - 12/2004
14Pentylenetetrazole (Metrazol)IBA
09/2023 - 04/2002
14DNA (Deoxyribonucleic Acid)IBA
01/2023 - 11/2007
14Anticonvulsants (Antiepileptic Drugs)IBA
01/2023 - 11/2005
14Histidine (L-Histidine)FDA Link
01/2016 - 04/2002
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2024 - 11/2005
11LipidsIBA
03/2024 - 07/2010
11Androgen Receptors (Androgen Receptor)IBA
01/2021 - 07/2009
11CarnosineIBA
02/2015 - 05/2006
10Small Interfering RNA (siRNA)IBA
01/2022 - 08/2005
9GadoliniumIBA
04/2024 - 04/2013
9Neuroprotective AgentsIBA
01/2023 - 01/2004
9Cisplatin (Platino)FDA LinkGeneric
01/2020 - 11/2007
8ChromatinIBA
02/2024 - 06/2010
8CateninsIBA
11/2023 - 01/2018
7Anti-Bacterial Agents (Antibiotics)IBA
05/2024 - 04/2012
7CalciumIBA
03/2024 - 06/2016
7AntigensIBA
11/2023 - 09/2002
7AndrogensIBA
11/2023 - 07/2009
7HMGB1 Protein (HMG1)IBA
09/2023 - 01/2015
7Histamine H1 Receptors (Histamine H1 Receptor)IBA
01/2023 - 03/2007
7Histamine H3 Receptors (Histamine H3 Receptor)IBA
11/2022 - 11/2004
7Neurotransmitter Agents (Neurotransmitter)IBA
10/2022 - 02/2012
7Interleukin-6 (Interleukin 6)IBA
04/2022 - 01/2004
7LigandsIBA
01/2022 - 03/2015

Therapy/Procedure

109Therapeutics
05/2024 - 06/2003
16Drug Therapy (Chemotherapy)
05/2024 - 05/2007
13Immunotherapy
03/2024 - 09/2002
12Stents
05/2023 - 07/2003
11Cardiac Resynchronization Therapy
10/2019 - 01/2014
10Radiotherapy
01/2023 - 12/2005
9Ligation
08/2022 - 07/2003
8Hepatectomy
03/2024 - 07/2017
8Transplantation
01/2020 - 08/2004
7Catheters
05/2024 - 06/2007
7Deep Brain Stimulation
01/2024 - 10/2008
7Intraperitoneal Injections
09/2023 - 05/2006
7Electrodes (Electrode)
11/2022 - 11/2005
7Aftercare (After-Treatment)
09/2022 - 04/2007
7Lasers (Laser)
01/2022 - 12/2004